Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR | ADC payloads to Fc mutations: advancing bioanalysis for novel modalities 14 days 10 hours 15 mins 0 secs REGISTER NOW!

Targeted omics library: fast forward to results with MetaboQuan

13 Aug 2018
General interest

Learn how your lab can increase efficiencies while reducing costs in this overview of our MetaboQuan-R and LipidQuan-R method packages. Hear from Billy Molloy, Senior Applications Scientist at Waters Corporation, as he discusses how the rapid, Targeted Omics Method packages were developed to run multiple different analyses without the need to change columns and mobile phases.

 

 

 

 

 

LB_Q3-spotlight-view

Top content

  • Small molecule method development strategies with Chad Christianson
  • New AI tool predicts multiple sclerosis drug response
  • Waters upgrade Xevo MRT performance: who doesn’t want sharper, faster imaging?

Related tags

biomarker validation metabolism Waters
Previous article Next article

Related articles

29 NOV 2017 JOURNAL ARTICLES
Mass spectrometry based metabolomics: a novel analytical technique for detecting metabolic syndrome?
29 OCT 2019 GENERAL INTEREST
Antibody–drug conjugate drug-to-antibody ratio analysis in serum using IA-LC-HRMS
30 JUN 2011 CLINICAL
Book Review: Drug Development Perspectives: Considerations, Challenges and Strategies 
3 MAR 2015 NEWS
Light microscopy technique could enable visualization of complex protein metabolism in living systems
7 JAN 2019 BIOANALYSIS RISING STAR AWARD
Bioanalysis Rising Star Award 2018
23 MAR 2011 JOURNAL ARTICLES
Specificity of bioanalytical methods for pharmacokinetic support of biological macromolecular therapeutics is important
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone